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Abstract  26 
Many proteins initially identified in the immune system play roles in neurogenesis, neuronal 27 
migration, axon guidance, synaptic plasticity and other processes related to the formation and 28 
refinement of neural circuits. Although the function of the immune-related protein Galectin-3 29 
(LGALS3) has been extensively studied in the regulation of inflammation, cancer and 30 
microglia activation, little is known about its role in the development of the brain. In this 31 
study, we identified that LGALS3 is expressed in the developing postnatal cerebellum. More 32 
precisely, LGALS3 is expressed by cells in meninges and in the choroid plexus, and in 33 
subpopulations of astrocytes and of microglial cells in the cerebellar cortex. Analysis of 34 
Lgals3 knockout mice showed that Lgals3 is dispensable for the development of cerebellar 35 
cytoarchitecture and Purkinje cell excitatory synaptogenesis in the mouse.  36 
 37 
Introduction 38 
Many proteins initially identified in the immune system are also expressed in the developing 39 
and adult central nervous system (CNS) and contribute to a variety of processes during the 40 
formation and refinement of neural circuits. Immune system molecules play roles in 41 
neurogenesis, neuronal migration, axon guidance and synaptic plasticity (Reviewed in [1,2]). 42 
For example, the complement system proteins C1Q and C3, and the transmembrane major 43 
histocompatibility complex molecule class I (MHC-I) participate in the promotion of synapse 44 
elimination in the developing retinogeniculate pathway and in the vertebrate neuromuscular 45 
junction [3,4]. C1Q-related proteins such as the cerebellins and the C1Q-like proteins are 46 
known to be essential for synaptogenesis [5–8]. All these immune and immune-related 47 
proteins are expressed in neurons [3–8]. 48 
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Galectins are a class of secreted lectins that play roles in various organs including the immune 49 
system. Galectins have been involved in inflammation, tumorigenesis, cancer, cell growth and 50 
metastasis [9–12]. They regulate cell migration, adhesion to the extracellular matrix, and cell-51 
survival depending on their intra- or extracellular location [13]. The mammalian galectin 52 
family of soluble lectins is composed of fifteen members, all of which share a homologous 53 
carbohydrate recognition domain (CRD) that typically binds β-galactoside residues [14]. 54 
There are three architectural types of galectins: proto, tandem-repeat and chimera. The proto-55 
galectins (Galectin-1, 2, 5, 7, -10, -11, -13, -14 and -15) present two homologous CRD 56 
(homodimers); the tandem-repeat-galectins (Galectin-4, 6, 8, -9 and -12) are composed by 57 
two distinct CRD (heterodimers). Both proto and tandem-repeat galectins have only 58 
carbohydrates as ligands. The pleiotropic LGALS3 is the only chimera type of galectins, and 59 
is particular in that in addition to the CRD domain, it contains a domain that enables its 60 
interaction with non-carbohydrate ligands [15] and the formation of pentamers and 61 
heterogeneous complexes with multivalent carbohydrates [16]. LGALS3 has been shown to 62 
interact with a broad collection of partners and to play roles at different time points during the 63 
life of the cell, including growth, adhesion, differentiation, cell-cycle and apoptosis [15]. 64 
Finally LGALS3 is involved in various pathologies such as cancer, inflammation and heart 65 
disease [17–19]. 66 
The role of LGALS3 in the central nervous system remain poorly understood. LGALS3 has 67 
been proposed to play a role in brain pathology. Its expression is increased in microglial cells 68 
upon various neuroinflammatory stimuli as, for instance, after ischemic injury [20,21]. 69 
LGALS3 binds the toll-like receptor 4 (TLR4) and promotes activation of microglia, a 70 
function that might promote the inflammatory response and neuronal death after ischemia 71 
[18]. The expression of LGALS3 also increases in reactive astrocytes in the injured cerebral 72 
cortex [19]. The role of LGALS3 in normal brain development and function has little been 73 
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explored. LGALS3 is expressed in the subventricular zone, precisely in astrocytes around 74 
neuroblasts, and loss of LGALS3 reduces neuronal migration from the subventricular zone to 75 
the olfactory bulb in vivo [22]. LGALS3 plays also a role in oligodendrocyte differentiation 76 
and contributes to myelin function [23]. It has been shown that LGALS3 is not expressed in 77 
neurons in the olfactory bulb [22] or that it is only expressed in neurons under conditions of 78 
acute brain inflammation in the hippocampus [18] or in the injured cerebral cortex [19]. 79 
However, recently, LGALS3 has been reported to be expressed in hippocampal neurons and 80 
to play a role in memory formation through its interaction with integrin α3 [24]. LGALS3 can 81 
interact with the cell adhesion molecule integrin α3β1 [25], and integrin β1 induces the 82 
expression of LGALS3 in vitro [26]. While integrins have been involved in synaptogenesis 83 
and synapse modulation, the role of LGALS3 in these processes has not been explored so far. 84 
In this study, we investigated the expression and the role of Lgals3 during development of the 85 
olivocerebellar network in the mouse. The connectivity and physiology of this neuronal 86 
network, and its development, have been well described, making it an ideal model to study 87 
the molecular mechanisms regulating the development of neuronal networks. Our data show 88 
that while LGALS3 is expressed during postnatal development in the olivocerebellar network, 89 
it is mainly expressed by glial cells, and it is dispensable for neuronal development and 90 
synaptogenesis in this structure.  91 
 92 
Material and methods 93 
Ethics Statement 94 
All animal protocols were approved by the Comité Regional d’Ethique en Experimentation 95 
Animale (# 00057.01). 96 
 97 
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Animals 98 
Lgals3+/+ wild-type and Lgals3-/- knockout littermates were obtained by breeding 99 
heterozygotes (129Sv background) and were kindly provided by Dr. Françoise Poirier [27]. 100 
CX3CR1eGFP/eGFP mice were kindly provided by Dr. Etienne Audinat and Prof. S. Jung [28]. 101 
 102 
Antibodies 103 
The following primary antibodies were used: mouse monoclonal anti-CABP (1:1000; swant, 104 
Cat#300), rabbit polyclonal anti-CABP (1:1000; swant, Cat#9.03), mouse monoclonal anti-105 
GFAP (1:500; millipore, Cat#MAB360), rabbit polyclonal anti-GLURδ1/2 (1:1000; 106 
millipore, Cat#AB2285), goat polyclonal anti-LGALS3 (1:200; R&D Systems, Cat#AF1197), 107 
mouse monoclonal anti-OLIG2 (1:500; millipore, Cat#MABN50), guinea pig polyclonal anti-108 
VGLUT1 (1:5000; millipore, Cat#AB5905) and guinea pig polyclonal anti-VGLUT2 109 
(1:5000; millipore, Cat#AB2251). The following secondary antibodies were used: donkey 110 
polyclonal anti-goat Alexa Fluor 568 (1:1000; invitrogen, Cat#A11057), donkey polyclonal 111 
anti-mouse Alexa Fluor 488 (1:1000; invitrogen, Cat#R37114), donkey polyclonal anti-rabbit 112 
Alexa Fluor 488 (1:1000; invitrogen, Cat#A21206) and goat polyclonal anti-guinea pig Alexa 113 
Fluor 594 (1:1000; Invitrogen, Cat#A11076). 114 
 115 
RTqPCR 116 
RNA samples were obtained from cerebellar and brainstem tissues using the RNeasy Mini kit 117 
(QIAGEN, Hilden, Germany) and cDNA amplified using the SuperScript® VILOTM cDNA 118 
Synthesis kit (life technologies, Paisley, UK) according to manufacturer’s instructions. 119 
Quantitative PCR was performed using the TaqMan Universal Master Mix II with UNG 120 
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(Applied Biosystems, Courtboeuf, France) and the following TaqMan probes: Rpl13a 121 
(#4331182_Mm01612986_gH) and Lgals3 (#4331182_ Mm00802901_m1).  122 
 123 
Immunohistochemistry 124 
Immunostaining was performed on 30μm-thick parasagittal sections obtained using a freezing 125 
microtome from brains of mice perfused with 4% paraformaldehyde in phosphate buffered 126 
saline (PBS) solution. Sections were washed three times for five minutes in PBS, then 127 
blocked with PBS 4% donkey serum (DS; abcam, Cat#ab7475) for 30 minutes. The primary 128 
antibodies were diluted in PBS, 1% DS, 1% Triton X-100 (Tx; sigma-aldrich, Cat#x100). The 129 
sections were incubated in the primary antibody solution overnight at 4ºC and then washed 130 
three times for five minutes in PBS 1%Tx. Sections were incubated in the secondary 131 
antibody, diluted in PBS 1%DS 1%Tx solution, for 1h at room temperature. The sections 132 
were then incubated for 15 minutes with the nuclear marker Hoechst 33342 (sigma-aldrich, 133 
Cat#H6024), followed by three washes for five minutes in PBS 1%Tx and recovered in PBS. 134 
The sections were mounted with Prolong Gold (invitrogen; Cat#P36960). 135 
 136 
Image acquisition and analysis 137 
Imaging was performed using confocal microscopy (SP5, leica). The pinhole aperture was set 138 
to 1 Airy Unit and a z-step of 500 nm was used. The software ImageJ was used to measure 139 
the area of the cerebellum from images of staining obtained with the nuclear marker Hoechst, 140 
and the area and the length of the molecular layer using images of the anti-CABP staining. 141 
 142 
Statistical Analysis 143 
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Data generated with ImageJ were imported in GraphPad Prism for statistical analysis. Values 144 
are given as mean ± s.e.m. Normality was assessed using the Kolmogorov-Smirnov normality 145 
test. Differences between two groups were tested using the two-tailed Student’s t-test. Groups 146 
were considered significantly different when at least a 95% confidence level (P<0.05) was 147 
obtained.  148 
 149 
Results 150 
Lgals3 mRNA is expressed in the cerebellum and brainstem 151 
during postnatal development. 152 
The expression level of Lgals3 mRNA in the cerebellum was measured using quantitative 153 
RT-PCR at different time points during late embryonic and postnatal development. The 154 
expression of Lgals3 mRNA is developmentally regulated in the cerebellum (Fig 1A). It 155 
peaks at P14 when it quadruples compared to the levels detected at E17 and P0 and returns to 156 
the levels detected during the first postnatal week by P21, a stage when neurogenesis, 157 
differentiation and synaptogenesis in the cerebellum is to a large extent complete [29]. This 158 
developmentally regulated expression profile is similar to the mRNA expression profile of the 159 
adhesion G protein coupled receptor BAI3, that was recently shown to regulate Purkinje cell 160 
synaptogenesis [5,7]. This pattern thus suggested a role for LGALS3 during cerebellar 161 
Purkinje cell development and excitatory synaptogenesis. 162 
 163 
Fig 1. The cerebellar architecture is not affected in Lgals3 null mice. (A) Lgals3 mRNA 164 
expression relative to Rpl13a measured by RTqPCR in the cerebellum during development. 165 
E17: embryonic day 17. P0, P7, P14, and P21: postnatal day 0, 7, 14, and 21. (B) Lgals3 166 
knockout (KO) mice present no defects in cerebellar morphology. Parasagittal cerebellar 167 
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slices of wild-type (WT) and Lgals3 KO adult mice were stained using the nuclear marker 168 
Hoechst.  169 
 170 
Cerebellar architecture and excitatory synaptogenesis are not 171 
affected by Lgals3 invalidation. 172 
To study the role of LGALS3 in the development of the cerebellum, we analyzed mice 173 
invalidated for the Lgals3 gene [27]. The general architecture of the cerebellum, the different 174 
layers and folia, was normal in those mice (Fig 1B). Quantitative analysis showed a slight 175 
decrease (less than 10%) in the mean area of the cerebellum and in the mean area and length 176 
of the molecular layer in adult Lgals3 knockout (KO) mice when compared to Lgals3 wild-177 
type (WT) mice (mean cerebellar area: 10.39x106±1.72x105 µm2 versus 9.62x106±2.34x105 178 
µm2, P=0.0235; mean molecular layer area: 4.9x106±0.81x105 µm2 versus 4.42x106±0.72x105 179 
µm2, P=0.0015; mean molecular layer length: 115.95±1.65 µm versus 105.5±1.53 µm, 180 
P=0.000082; for WT and KO six months-old mice, respectively; Student’s t-test; n=3 animals 181 
per genotype). These small differences were associated with a decrease in body weight in 182 
adult KO (mean body weight ± s.e.m.: 26.033±0.07 g for WT, 24.003±0.66 g for KO; n=5 183 
animals per genotype, P=0.027, Student’s t-test). These results show that lack of LGALS3 184 
does not have a major effect on neurogenesis and neuronal morphogenesis in the cerebellum.  185 
Lgals3 expression peaks at postnatal day 14 (Fig 1A), a period of intense synaptogenesis in 186 
the cerebellar cortex, and LGALS3 potentially interacts with integrin β1 that is present at the 187 
Climbing fiber (CF)-Purkinje cell synapse [25,30]. To analyze the possible role of LGALS3 188 
in excitatory synapse formation we used immunolabeling with the pre-synaptic marker 189 
VGLUT2, to label the CF presynaptic boutons, and with the pre-synaptic marker VGLUT1, 190 
specific for the parallel fiber (PF) presynaptic boutons in the cerebellar cortex. At P15, 191 
VGLUT2 clusters are found on the somato-dendritic region of Purkinje cells, in particular on 192 
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proximal dendrites both in Lgals3 KO and Lgals3 WT mice (Fig 2A). Smaller VGLUT2 193 
clusters corresponding to maturing PF-Purkinje cell synapses [31] are found in distal 194 
dendrites, in particular in the upper part of the molecular layer, in both genotypes. In adult 195 
mice, when CF and PF synapses are mature, VGLUT2 clusters are only found on the Purkinje 196 
cells proximal dendrites and extend to about 4/5th of the molecular layer height both in Lgals3 197 
KO and WT cerebella (Fig 2B). The pattern of VGLUT1 immunostaining is similar in Lgals3 198 
KO mice and control littermates, with a sparse staining of distal dendrites at P15 (Fig 2C) and 199 
a dense staining non-overlapping with the VGLUT2 clusters at P65 (Fig 2D). These 200 
qualitative data show that both PF and CF excitatory synaptogenesis in cerebellar Purkinje 201 
cells is not affected by Lgals3 invalidation.  202 
 203 
Fig 2. No changes in excitatory Purkinje cell synapses in Lgals3 knockout mice. (A and 204 
B) Immunostaining for the Purkinje cell marker CABP (green) and the presynaptic marker 205 
VGLUT2 (red) was performed on sections from Lgals3 WT and KO mice at P15 (A) and at 206 
P65 (B). (C and D) Immunostaining for the Purkinje cell marker CABP (green) and the 207 
presynaptic marker VGLUT1 (red) specific for mature parallel fiber synapses was performed 208 
on sections from Lgals3 WT and KO mice at P15 (C) and at P65 (D). Scale bar: 25μm. Data 209 
are representative of three independent experiments. 210 
 211 
LGALS3 is expressed in glia in the cerebellum 212 
The lack of effect on cerebellar morphology and synaptogenesis of Lgals3 invalidation raised 213 
the question as to what type of cells express the LGALS3 protein during postnatal 214 
development. Using a LGALS3 antibody, we localized LGALS3 expression in the cerebellum 215 
and brainstem during postnatal development. The specificity of the antibody was confirmed 216 
by the lack of immunoreactivity in cerebellar sections from Lgals3 KO mice (n=3 217 
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independent experiments; Fig 3A). At P15, the highest expression of LGALS3 was found in 218 
the choroid plexus located above the cerebellum, and in the ependymal cells and meningeal 219 
cells lining the cerebral aqueduct and the 4th ventricle. In the cerebellar cortex, the white 220 
matter is strongly stained, while rare scattered cells in the grey matter also display some 221 
LGALS3 expression. Despite a more than two-fold decrease in Lgals3 mRNA levels in the 222 
cerebellum between P14 and P21 (Fig 1A), the pattern of LGALS3 immunostaining was 223 
similar at P15 and P22 (Fig 3B and C respectively). At P15, Purkinje cells display a staining 224 
that is barely distinguishable from background, and that completely disappears at P21. In the 225 
brainstem, LGALS3 immunostaining was mainly found in the white matter underneath the 4th 226 
ventricle, between the pons (medial vestibular nucleus) and the medulla (pontine central grey) 227 
at both P15 and P22 (Figs 3B-C).  228 
 229 
Fig 3. LGALS3 expression in the cerebellum and brainstem during postnatal 230 
development. (A) Immunohistochemistry for LGALS3 show the specificity of the LGALS3 231 
antibody. WT: wild-type mice; KO: knockout mice. Positive cells in the molecular layer are 232 
marked with a white arrowhead, scale bar 50μm. (B) Immunohistochemistry for the Purkinje 233 
cell marker CABP (green) and LGALS3 (red) on parasagittal cerebellar sections from P15 234 
and P22 wild-type mice. Scale bar=100μm. Data are representative of three independent 235 
experiments. Legends: 4V, 4th ventricle; chp, choroid plexus; pcg, pontine central gray and 236 
mv, medial vestibular nucleus. 237 
 238 
The cerebellar white matter contains both oligodendrocytes and astrocytes. Previous studies 239 
have detected LGALS3 expression in Schwann cells of the peripheral nervous system [32] 240 
and in oligodendrocytes at different stages of maturation [23]. Co-immunostaining 241 
experiments using an antibody against the oligodendrocyte specific marker OLIG-2 show 242 
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some LGALS3 expression in OLIG-2 positive oligodendrocytes (Fig 4A), while co-243 
immunostaining experiments with an anti-GFAP antibody to label astrocytes showed 244 
extensive colocalization of LGALS3 and GFAP in cells of the cerebellar white matter (Fig 245 
4B). In the grey matter of the cerebellum, the morphology of scattered LGALS3 positive cells 246 
was reminiscent of microglial cells. Immunolabeling of cerebellar sections from a 247 
CX3CR1eGFP/eGFP mouse line that expresses soluble GFP in microglial cells [28], revealed 248 
double labeled cells and confirmed the microglial identity of LGALS3 positive cells in the 249 
molecular layer (Fig 4C). Overall our study shows that LGALS3 is expressed in non-neuronal 250 
cells in the cerebellum and brainstem during postnatal development, in particular 251 
subpopulations of astrocytes and microglial cells.  252 
 253 
Fig 4. LGALS3 protein expression in meningeal cells and in glial cells of the cerebellar 254 
cortex of the adult mice. (A) LGALS3 expression in oligodendrocytes in the cerebellar white 255 
matter. Co-immunostaining of parasagittal cerebellar slices using anti-LGALS3 (red), 256 
oligodendrocyte marker anti-OLIG-2 (green) and the nuclear marker Hoechst (blue). (B) 257 
LGALS3 expression in astrocytes in the cerebellar white matter. Co-immunostaining of 258 
parasagittal cerebellar slices using anti-LGALS3 (red), astrocyte marker anti-GFAP (green) 259 
and the nuclear marker Hoechst (blue). (C) LGALS3 expression in some microglial cells of 260 
the molecular layer. Immunostaining anti-LGALS3 (red) in parasagittal sections of mice 261 
CX3CR1eGFP/eGFP, microglial CX3CR1-GFP (green) and the nuclear marker Hoechst (blue). 262 
Scale bar 50μm and 20μm for the magnification. Data are representative of three independent 263 
experiments. Legends: 4V, 4th ventricle; GL, granular layer; ML, molecular layer and WM, 264 
white matter. 265 
 266 
Discussion  267 
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The role of LGALS3 in the development of the CNS remains poorly studied. We show that 268 
during postnatal development, LGALS3 is expressed in the choroid plexus in the fourth 269 
ventricle, as well as in a subset of glial cells in the cerebellar cortex. This expression is 270 
dispensable for the development of the normal cytoarchitecture of the cerebellum and 271 
excitatory synaptogenesis in Purkinje cells. 272 
LGALS3 expression has been described previously in pathological conditions in the 273 
mammalian brain, in particular after ischemia [20,21]. LGALS3 is expressed by a subset of 274 
proliferating astrocytes that contribute to reactive gliosis [19]. In the normal brain, high 275 
expression of LGALS3 has been found in the subventricular zone, rostral migratory stream 276 
and olfactory bulb [22] and in the subependymal zone of the lateral ventricles [19]. Our 277 
results are in concordance, showing high expression of LGALS3 in the choroid plexus 278 
beneath the cerebellum and in the subependymal zone of the fourth ventricle. In the brain 279 
parenchyma, some studies have reported neuronal expression of LGALS3 in the hippocampus 280 
and cerebellum [24,33,34], while others did not detect any neuronal expression [19,35]. In the 281 
cerebellum in particular, low levels of mRNA expression were reported in Purkinje cells and 282 
granule cells in an analysis of Allen Brain Atlas data by John and Mishra [33]. Our results 283 
showed very low to undetectable expression of LGALS3 in cerebellar neurons, in agreement 284 
with previous results [35,36]. However high levels of LGALS3 were found in subsets of 285 
astrocytes and subsets of microglia in the cerebellar cortex. This is in accordance with 286 
previous results showing expression of LGALS3 by microglia [18] and astrocytes in vitro 287 
[23]. LGALS3 has been involved in myelination [23]. Our results show some expression of 288 
LGALS3 in oligodendrocytes of the cerebellar white matter during postnatal development. 289 
Together with its expression in astrocytes of the white matter, this suggests an implication of 290 
LGALS3 in the crosstalk between astrocytes and oligodendrocytes during myelination 291 
(reviewed in [37]). 292 
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Several reasons suggested a role for Lgals3 during synaptogenesis. First, LGALS3 is a 293 
secreted and immune-related protein with a developmentally regulated mRNA expression 294 
profile that coincides with the timing of excitatory synaptogenesis in the cerebellum. These 295 
characteristics are shared by C1QL1 and CBLN1, two major synaptogenic proteins of the CF-296 
Purkinje cell and PF-Purkinje cell synapses respectively [5–8][5–8]. Second, LGALS3 297 
promotes neural cell adhesion and neurite outgrowth in cultured neurons [38]. Third it has 298 
been shown that LGALS3 interacts functionally with integrins, adhesion proteins known to 299 
play roles in synaptogenesis and synapse modulation. Integrin α3β1 is necessary for the 300 
organization of the cerebellar excitatory synapse CF-Purkinje cell [30], LGALS3 can interact 301 
with integrin α3β1 [25], and integrin β1 induces the expression of LGALS3 in culture [26]. 302 
Our analysis of the Lgals3 knockout mouse did not find any major perturbation of Purkinje 303 
cell excitatory synaptogenesis in the absence of LGALS3. Our data thus indicate that either 304 
LGALS3 plays no role in synaptogenesis, or that other proteins play redundant functions.  305 
Our results do not exclude a role for LGALS3 in regulating synapse maturation and function. 306 
In particular, microglia have been involved in synapse elimination during development of the 307 
visual system [3], and LGALS3 promotes phagocytosis of PC12 cells by microglia [39]. 308 
Activity-dependent synapse refinement of the CF-Purkinje cell synapse happens largely 309 
during the first three postnatal weeks [29]. Given LGALS3 expression in microglial cells in 310 
the cerebellar cortex during this period, it would be interesting to test whether LGALS3 is 311 
involved in climbing fiber synapse elimination, in particular, through its interaction with 312 
integrin α3β1, a known regulator of CF synaptogenesis. 313 
 314 
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